These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16541356)

  • 41. A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer.
    Gatzemeier U; Manegold C; Eberhard W; Wilke HJ; Chomy F; Chomy P; Khayat D; Blatter J; Seeber S; Drings P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-36-S8-38. PubMed ID: 9207315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig model.
    Pagès PB; Facy O; Mordant P; Ladoire S; Magnin G; Lokiec F; Ghiringhelli F; Bernard A
    PLoS One; 2013; 8(3):e59485. PubMed ID: 23527205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
    Le Chevalier T; Gottfried M
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes.
    Salman HS; Tanaka K; Sparano JA
    Clin Breast Cancer; 2002 Jan; 2(4):299-303. PubMed ID: 11899362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
    Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study.
    Lemarie E; Vecellio L; Hureaux J; Prunier C; Valat C; Grimbert D; Boidron-Celle M; Giraudeau B; le Pape A; Pichon E; Diot P; el Houfia A; Gagnadoux F
    J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):261-70. PubMed ID: 21793717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).
    Ferrigno D; Buccheri G;
    Lung Cancer; 2004 Sep; 45(3):373-80. PubMed ID: 15301878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: a Hoosier Oncology Group study.
    Einhorn LH
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-24-S8-26. PubMed ID: 9207312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
    Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.
    Ng EW; Sandler AB; Robinson L; Einhorn LH
    Am J Clin Oncol; 1999 Dec; 22(6):550-3. PubMed ID: 10597737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.
    Thatcher N; Jayson G; Bradley B; Ranson M; Anderson H
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-6-S8-12. PubMed ID: 9207309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.
    Davis JL; Pandalai P; Ripley RT; Langan RC; Steinberg SM; Walker M; Toomey MA; Levy E; Avital I
    Trials; 2011 May; 12():129. PubMed ID: 21595953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.
    Jia SF; Worth LL; Turan M; Duan Xp XP; Kleinerman ES
    Anticancer Drugs; 2002 Feb; 13(2):155-61. PubMed ID: 11901308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.
    Gatzemeier U; Groth G; Butts C; Van Zandwijk N; Shepherd F; Ardizzoni A; Barton C; Ghahramani P; Hirsh V
    Ann Oncol; 2004 Jan; 15(1):19-27. PubMed ID: 14679114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 56. Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study.
    Karampeazis A; Vamvakas L; Kotsakis A; Christophyllakis C; Kentepozidis N; Chandrinos V; Agelidou A; Polyzos A; Tsiafaki X; Hatzidaki D; Georgoulias V
    J Geriatr Oncol; 2017 Jan; 8(1):23-30. PubMed ID: 27264267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
    Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
    Sandler AB; Kindler HL; Einhorn LH; Mitchell E; Masters G; Kraut M; Nicol S; Raghavan D
    Ann Oncol; 2000 Sep; 11(9):1161-4. PubMed ID: 11061612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of deoxycytidine kinase in gemcitabine cytotoxicity.
    van der Wilt CL; Kroep JR; Bergman AM; Loves WJ; Alvarez E; Talianidis I; Eriksson S; van Groeningen CJ; Pinedo HM; Peters GJ
    Adv Exp Med Biol; 2000; 486():287-90. PubMed ID: 11783501
    [No Abstract]   [Full Text] [Related]  

  • 60. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.